HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Adamantia Nikolaidi Selected Research
Adamantia Nikolaidi Research Topics
Disease
3
Neoplasms (Cancer)
01/2022 - 03/2020
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2023 - 01/2022
2
Breast Neoplasms (Breast Cancer)
01/2020 - 08/2013
1
Autoimmune Diseases (Autoimmune Disease)
01/2022
1
Ovarian Neoplasms (Ovarian Cancer)
01/2022
1
Carcinoma (Carcinomatosis)
01/2022
1
Pancreatic Neoplasms (Pancreatic Cancer)
06/2021
1
Osteonecrosis (Kienbock's Disease)
07/2020
1
Drug-Related Side Effects and Adverse Reactions
01/2020
1
Circulating Neoplastic Cells
01/2019
1
Colorectal Neoplasms (Colorectal Cancer)
01/2019
1
Oral Ulcer (Mouth Ulcer)
08/2013
1
Stomatitis
08/2013
Drug/Important Bio-Agent (IBA)
2
Nivolumab
IBA
06/2023 - 01/2022
2
Immune Checkpoint Inhibitors
IBA
06/2023 - 01/2022
2
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2019
2
Hormones (Hormone)
IBA
01/2020 - 08/2013
1
Platinum
IBA
01/2022
1
Bevacizumab (Avastin)
FDA Link
01/2022
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2022
1
pembrolizumab
IBA
01/2022
1
Gemcitabine
FDA Link
06/2021
1
Tinzaparin (Innohep)
FDA Link
06/2021
1
130-nm albumin-bound paclitaxel
IBA
06/2021
1
Paraffin
IBA
03/2020
1
ErbB Receptors (EGF Receptor)
IBA
01/2020
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
01/2020
1
Cyclin-Dependent Kinase 4
IBA
01/2020
1
aflibercept
IBA
01/2019
1
exemestane (Aromasin)
FDA Link
08/2013
1
Everolimus
FDA Link
08/2013
Therapy/Procedure
3
Immunotherapy
01/2022 - 01/2022
3
Drug Therapy (Chemotherapy)
01/2022 - 01/2020
2
Therapeutics
01/2020 - 01/2019
1
Neoadjuvant Therapy
01/2022
1
Cytoreduction Surgical Procedures
01/2022
1
Low-Level Light Therapy (LLLT)
07/2020
1
Complementary Therapies (Alternative Medicine)
07/2020
1
Lasers (Laser)
07/2020